These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 331594

  • 1. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.
    Burleson RL, Jones DB, Yenikomshian A, DeVoe C, DeRito J.
    Transplant Proc; 1977 Sep; 9(3):1591-6. PubMed ID: 331594
    [Abstract] [Full Text] [Related]

  • 2. Donor pretreatment in an unselected series of cadaver renal allografts.
    Guttmann RD, Morehouse DD, Meakins JL, Klassen J, Knaack J, Beaudoin JG.
    Kidney Int Suppl; 1978 Jun; (8):S99-102. PubMed ID: 357821
    [Abstract] [Full Text] [Related]

  • 3. Pretreatment of cadaver donors with methylprednisolone in human renal allografts.
    Chatterjee SN, Terasaki PI, Fine S, Schulman B, Smith R, Fine RN.
    Surg Gynecol Obstet; 1977 Nov; 145(5):729-32. PubMed ID: 333644
    [Abstract] [Full Text] [Related]

  • 4. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts.
    Pechan W, Novick AC, Stowe N, Magnusson M, Straffon RA.
    Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225
    [Abstract] [Full Text] [Related]

  • 5. Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.
    McCabe R, Swistel A, Lorieo D, Fitzpatrick HF.
    Transplant Proc; 1980 Jun; 12(2):355-7. PubMed ID: 6156529
    [No Abstract] [Full Text] [Related]

  • 6. Prolongation of kidney allograft survival in dogs with donor pretreatment.
    Chassot PG, Beaudoin JG, Guttmann RD.
    Surg Forum; 1974 Jun; 25(0):314-6. PubMed ID: 4612787
    [No Abstract] [Full Text] [Related]

  • 7. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H, Woods JE, Roses J, Kimbler RW.
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [Abstract] [Full Text] [Related]

  • 8. The enhancing effect of donor pretreatment and low dose immunosuppression in dogs.
    Swistel AJ, McCabe RE, Lorieo DR, Wildstein A, Pierce JC, Fitzpatrick HF.
    Proc Clin Dial Transplant Forum; 1976 Nov; 8():93-5. PubMed ID: 386328
    [No Abstract] [Full Text] [Related]

  • 9. Modification of donor pretreatment prolongs canine renal allograft survival.
    Dienst SG, MacDonald R, Toledo-Pereyra LH, Fox B.
    Transplant Proc; 1979 Jun; 11(2):1465-6. PubMed ID: 382541
    [No Abstract] [Full Text] [Related]

  • 10. Improved survival of heart transplants. Graft and/or donor pretreatment with antilymphoblast globulin, cyclophosphamide, or methylprednisolone.
    Toledo-Pereyra LH, Condie RM.
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):536-41. PubMed ID: 347179
    [Abstract] [Full Text] [Related]

  • 11. New approaches to immunosuppression in renal transplantation.
    Stuart FP.
    Urol Clin North Am; 1976 Oct; 3(3):575-96. PubMed ID: 790732
    [Abstract] [Full Text] [Related]

  • 12. Prolonged kidney allograft survival with promethazine.
    Dunn DC, Wade J.
    Transplant Proc; 1979 Mar; 11(1):871-3. PubMed ID: 377721
    [Abstract] [Full Text] [Related]

  • 13. Pretreatment of cadaver donors with cyclophosphamide and methylprednisolone: effect on renal transplant outcome.
    Corry RJ, Patel NP, West JC, Schanbacher BA.
    Transplant Proc; 1980 Jun; 12(2):348-51. PubMed ID: 6994305
    [No Abstract] [Full Text] [Related]

  • 14. Cadaver Kidney transplantation. Effect of hypotension and donor pretreatment with methylprednisolone and phenoxybenzamine.
    Toledo-Pereyra LH, Simmons RL, Olson LC, Najarian JS.
    Minn Med; 1979 Mar; 62(3):159-61. PubMed ID: 370540
    [No Abstract] [Full Text] [Related]

  • 15. [The use of methylprednisolone in the therapy of renal transplants from cadavers].
    Selva S, Vallino F, Elli A, Trazzi R.
    Minerva Chir; 1980 Oct 31; 35(20):1581-8. PubMed ID: 7005747
    [Abstract] [Full Text] [Related]

  • 16. A prospective study of methylprednisolone and prednisone as immunosuppressive agents in clinical renal transplantation.
    Burleson RL, Marbarger PD, Jermanovich N, Brennan AM, Scruggs BF.
    Transplant Proc; 1981 Mar 31; 13(1 Pt 1):339-43. PubMed ID: 7022849
    [Abstract] [Full Text] [Related]

  • 17. Manipulation of allograft immunogenicity by pretreatment of cadaver donors.
    Guttmann RD.
    Urol Clin North Am; 1976 Oct 31; 3(3):475-90. PubMed ID: 790729
    [Abstract] [Full Text] [Related]

  • 18. The immunosuppressive activity of procarbazine hydrochloride in canine renal allografts by donor pretreatment.
    Varkarakis MJ, Abramczyk J, Brede HD, Murphy GP.
    J Surg Oncol; 1972 Oct 31; 4(3):235-47. PubMed ID: 4560767
    [No Abstract] [Full Text] [Related]

  • 19. Active enhancement of dog kidney allografts using ALG and donor platelets.
    Rowiński W, Ryffa T, Stepkowski S, Woźniewicz B, Ruka M, Wasowska B, Hay M, Olszewski W.
    Arch Immunol Ther Exp (Warsz); 1978 Oct 31; 26(1-6):1013-9. PubMed ID: 373670
    [Abstract] [Full Text] [Related]

  • 20. Modification of kidney graft survival in dog and man by pre-operative transfusion to the donor.
    Jeekel J, Van der Linden CJ, Vegt PA, Buurman WA, Harder F, Persijn G.
    Proc Eur Dial Transplant Assoc; 1980 Oct 31; 17():457-61. PubMed ID: 7017690
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.